Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.32 |
| ▸ | MAT2A | P31153 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.31 |
| ▸ | PPARA | Q07869 | 2/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21399413 | 0.96 | KIF11 (0.34) | KIF11PTGDR2MAT2APPARGPPARA | |
| SCHEMBL20848715 | 0.92 | CYP2C9 (0.31) | KIF11PTGDR2 | |
| SCHEMBL22985490 | 0.92 | ALOX5AP (0.34) | KIF11PTGDR2 | |
| SCHEMBL20849538 | 0.91 | PGR (0.32) | KDM4EATML3MBTL1 | |
| SCHEMBL22985228 | 0.90 | ALOX5AP (0.34) | KIF11PTGDR2 | |
| SCHEMBL22985520 | 0.90 | ALOX5AP (0.35) | KIF11PTGDR2 | |
| SCHEMBL20848805 | 0.90 | EDNRB (0.32) | KIF11PTGDR2 | |
| SCHEMBL20848548 | 0.89 | PDPK1 (0.31) | — | |
| SCHEMBL19047817 | 0.89 | KDM4E (0.38) | KDM4EATML3MBTL1 | |
| SCHEMBL20848508 | 0.88 | KIF11 (0.30) | KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292151-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | OR10J3, NR2E3, FOXO3 | KIF11 4281/4885PTGDR2 1288/4885MAT2A 3654/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.